Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|August 19, 2008
KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loopsOlga Martinho, Alberto Gonçalves, Marise A R Moreira, et al.
Oncology Reports|December 13, 2012
Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patientsOlga Martinho, Kleber Simões, Adhemar Longatto-Filho, et al.
Experimental and Therapeutic Medicine|August 17, 2018
In vitro screening of cytotoxic activity of euphol from Euphorbia tirucalli on a large panel of human cancer-derived cell linesViviane Aline Oliveira Silva, Marcela Nunes Rosa, Aline Tansini, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|February 10, 2016
Raf Kinase Inhibitor Protein Expression and Prognostic Value in Soft Tissue SarcomasOlga Martinho, Marcelo Campos, Guilherme Ribeiro, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|August 30, 2007
Molecular alterations of KIT oncogene in gliomasAna L Gomes, Jorge S Reis-Filho, José M Lopes, et al.
Plos One|February 1, 2012
Downregulation of RKIP is associated with poor outcome and malignant progression in gliomasOlga Martinho, Sara Granja, Teresa Jaraquemada, et al.
BMC Cancer|July 1, 2009
Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinomaAdhemar Longatto-Filho, Céline Pinheiro, Olga Martinho, et al.
Reproductive Biomedicine Online|April 12, 2024
Raf kinase inhibitor protein expression in smooth muscle tumours of the uterus: a diagnostic marker for leiomyosarcoma?Stefania Greco, Joana Pinheiro, Diana Cardoso-Carneiro, et al.
Neuro-Oncology|December 22, 2012
Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targetsVera Miranda-Gonçalves, Mrinalini Honavar, Céline Pinheiro, et al.
Pageof 6